Threatened preterm labour - analysis of the cytokine profile and progesterone treatment efficiency
- PMID: 27151935
- DOI: 10.1080/14767058.2016.1186638
Threatened preterm labour - analysis of the cytokine profile and progesterone treatment efficiency
Abstract
Objective: Preterm labour is defined as the onset of labour between weeks 23 and before 37 of gestation. The purpose of this study was to compare the cytokine profile in the blood serum of patients experiencing threatened premature labour, along with the time of delivery and the foetus body mass at birth.
Methods: The study included 89 women hospitalised at the Obstetrics and Gynaecology Clinical Hospital in the period 2011-2013. Group 1 comprised 31 patients diagnosed with threatened preterm labour, prior to tocolytic treatment. Group 2 comprised 32 patients with tocolytic treatment. Group 3 constituted the control group.
Results: Groups 1, 2 and 3 differed considerably in terms of the week of delivery of pregnancy (p = 0.006). Analogous results were obtained by analysing the body mass at birth, where a statistically significant difference in body mass at birth was found between Groups 1, 2 and 3 (p < 0.001). Our analysis focussed on the cytokine profile of the women included in the study, but no considerable changes in cytokine concentration were observed.
Conclusions: No statistically significant differences were found in the cytokine profile among those patients in normally progressing pregnancy or in threatened preterm labour. No suitability of progesterone treatment in threatened preterm labour was observed.
Keywords: Delivery; infections; neonatology; physiology of reproduction; prenatal care.
Similar articles
-
Prevention of preterm delivery with vaginal progesterone in women with preterm labour (4P): randomised double-blind placebo-controlled trial.BJOG. 2015 Jan;122(1):80-91. doi: 10.1111/1471-0528.13061. Epub 2014 Sep 11. BJOG. 2015. PMID: 25209926 Clinical Trial.
-
The NIFTY study: a multicentre randomised double-blind placebo-controlled trial of nifedipine maintenance tocolysis in fetal fibronectin-positive women in threatened preterm labour.Aust N Z J Obstet Gynaecol. 2014 Jun;54(3):231-6. doi: 10.1111/ajo.12179. Epub 2014 Feb 8. Aust N Z J Obstet Gynaecol. 2014. PMID: 24506318 Clinical Trial.
-
Progesterone for maintenance tocolytic therapy after threatened preterm labour: a randomised controlled trial.Aust N Z J Obstet Gynaecol. 2008 Feb;48(1):58-63. doi: 10.1111/j.1479-828X.2007.00803.x. Aust N Z J Obstet Gynaecol. 2008. PMID: 18275573 Clinical Trial.
-
Myth: tocolysis for prevention of preterm birth has a major role in modern obstetrics.Semin Fetal Neonatal Med. 2011 Oct;16(5):242-6. doi: 10.1016/j.siny.2011.04.008. Semin Fetal Neonatal Med. 2011. PMID: 21641289 Review.
-
Recent pharmacological advances in the treatment of preterm membrane rupture, labour and delivery.Expert Opin Pharmacother. 2004 Sep;5(9):1917-28. doi: 10.1517/14656566.5.9.1917. Expert Opin Pharmacother. 2004. PMID: 15330729 Review.
Cited by
-
Oral nifedipine and parenteral isoxsuprine in arresting preterm labor: A comparative study.J Family Med Prim Care. 2022 May;11(5):1845-1850. doi: 10.4103/jfmpc.jfmpc_1696_20. Epub 2022 May 14. J Family Med Prim Care. 2022. PMID: 35800477 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical